Information Provided By:
Fly News Breaks for July 31, 2017
ICLR
Jul 31, 2017 | 07:17 EDT
As noted earlier, SunTrust upgraded Icon to Buy from Hold. Analyst Sandy Draper expects the company's revenue growth to accelerate through 2019, driven by share gains and the recovery of its Pfizer (PFE) business. He expects Icon's EPS growth to grow by low to mid teen percentage levels due to cost controls and a sustained lower tax rate. Target to $126 from $93.